Covidien Articles
Covidien files Form 10 registration statement for planned spin-off of Pharma business
4 February 2013
Mallinckrodt to acquire CNS Thera for $100 million; Mediq to sell out for 775 million euros
25 September 2012
Covidien to spin off pharmaceuticals business
16 December 2011
US FDA briefs: fast-track for Zeltia’s Zentylor; OK for Baxter’s Protopam; warning on gadolinium-based contrast agents
13 September 2010
Showing 1-5 of 5 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
